La coronariografía precoz reduce la mortalidad en SCA sin supradesnivel del ST de alto riesgo

Compare-Acute Sub-Study: Natural History of Non-Culprit Lesions in MI

The aim of this study was to determine the prognostic value of fractional flow reserve (FFR) of non-culprit lesions in STEMI patients.  We analyzed data of all Compare-Acute patients (Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD) after PCI, from lesions assessed with FFR and treated medically.  The treating<a href="https://solaci.org/en/2020/06/16/compare-acute-sub-study-natural-history-of-non-culprit-lesions-in-mi/" title="Read more" >...</a>

Escándalo con los resultados del EXCEL que hicieron “caer” las últimas guías

More Data from the EXCEL and More Controversy

A thorough statistical analysis of the EXCEL has quite definitely shown that the likelihood of death, MI or stoke, including total mortality, is higher with PCI compared against CABG. The Bayesian analysis estimated a 3.3% difference in mortality, superior in the PCI arm, with 99% probability that EXCEL total mortality was indeed increased with PCI<a href="https://solaci.org/en/2020/06/08/more-data-from-the-excel-and-more-controversy/" title="Read more" >...</a>

Historia natural de la infección asintomática por COVID-19

Temporary Emergency Guidelines for Infarction During the Pandemic

Several United States societies (the American Heart Association [AHA] among them) have answered the question of many physicians in the front lines: what is the ideal strategy for the treatment of ST segment elevation myocardial infarction (STEMI) during the COVID-19 pandemic? This document intends to ensure that patients with STEMI continue to receive adequate, proven<a href="https://solaci.org/en/2020/06/03/temporary-emergency-guidelines-for-infarction-during-the-pandemic/" title="Read more" >...</a>

SOLACI PERIPHERAL | A New SOLACI Department

We are pleased to announce the creation of SOLACI’s new Department of Peripheral Endovascular Interventions. Its name is SOLACI PERIPHERAL and its objectives will be as follows: To promote continuing education for the community of interventional cardiologists involved in peripheral endovascular interventions. To collaborate in the organization of Congress sessions dedicated to peripheral interventions and other<a href="https://solaci.org/en/2020/05/12/solaci-peripheral-a-new-solaci-department/" title="Read more" >...</a>

Reperfusion in the Time of COVID-19. What Has Changed?

We are living a pandemic due to the new COVID-19, but the world was already in the midst of a pandemic of cardiovascular disease. Both challenges defy healthcare systems worldwide, and the worst part is that they can coexist. Some symptoms for both diseases can overlap (such as respiratory distress) and they are unreliable, like<a href="https://solaci.org/en/2020/04/17/reperfusion-in-the-time-of-covid-19-what-has-changed/" title="Read more" >...</a>

Interview with Dr. Gustavo Pedernera, New Director of the SOLACI Educational Newsletter

The SOLACI Educational Newsletter has a new director! It is Dr. Gustavo Pedernera, a prestigious clinical and interventional cardiologist, specialized in endovascular treatments at the Buenos Aires Cardiovascular Institute (Instituto Cardiovascular de Buenos Aires, ICBA), Argentina. Dr. Pedernera directed the Educational Newsletter #113 (dedicated to the treatment of chronic total occlusion) and was kind enough to talk to solaci.org about<a href="https://solaci.org/en/2020/04/15/interview-with-dr-gustavo-pedernera-new-director-of-the-solaci-educational-newsletter/" title="Read more" >...</a>

Es posible esterilizar las máscaras N95 y los barbijos quirúrgicos

Cardiology in Times of Coronavirus: The Perfect Storm

Since January 2020, the COVID-19 infection has spread from China to the rest of the world. The clinical picture has several points in common with influenza, being mild or asymptomatic in most cases. However, around 15% of cases shows complications with interstitial pneumonia that can lead to respiratory failure. Given the lack of vaccine or<a href="https://solaci.org/en/2020/04/14/cardiology-in-times-of-coronavirus-the-perfect-storm/" title="Read more" >...</a>

SOL SOLACI Performed a New Intervention During the Ecuador Sessions 2020

A new charitable case was featured at the Ecuador XL SOLACI Sessions 2020. At the CardioCentro Manta / Angiomanabí Clinic in Manta, Ecuador, physicians performed a successful closure of ductus arteriosus type A1 with an Amplatzer ADO I device (antegrade access). The patient was a 1-year old child admitted with a diagnosis of persistent ductus arteriosus. The case was sponsored by C.G MED.<a href="https://solaci.org/en/2020/04/14/sol-solaci-performed-a-new-intervention-during-the-ecuador-sessions-2020/" title="Read more" >...</a>

The Most Read Scientific Articles of March

01- Coronavirus and the Heart: How Should Cardiologists Prepare? As the number of confirmed cases increases throughout the globe, a picture is emerging as to what the direct cardiovascular effects of this pandemic may be. Read more HERE 02- TAVR: Should Transradial Approach be the Second Access Site? Courtesy of Dr. Carlos Fava. One of<a href="https://solaci.org/en/2020/04/08/the-most-read-scientific-articles-of-march/" title="Read more" >...</a>

ACC 2020 Virtual | Relación entre la severidad de la isquemia y la enfermedad coronaria

Virtual ACC 2020 | Relationship between Ischemia Severity and CAD

The ISCHEMIA trial enables countless sub-studies. Many of them have made part of the virtual ACC 2020, and among them you will find the present study.  This analysis finds it is the anatomy — rather than ischemia — which predicts events. And even more interesting is the fact that revascularizing this particular anatomy will not<a href="https://solaci.org/en/2020/04/01/virtual-acc-2020-relationship-between-ischemia-severity-and-cad/" title="Read more" >...</a>

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31